| Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity J Suurmond, B Diamond The Journal of clinical investigation 125 (6), 2194-2202, 2015 | 344 | 2015 |
| C1q and HMGB1 reciprocally regulate human macrophage polarization M Son, A Porat, M He, J Suurmond, F Santiago-Schwarz, U Andersson, ... Blood, The Journal of the American Society of Hematology 128 (18), 2218-2228, 2016 | 151 | 2016 |
| Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus S Malkiel, AN Barlev, Y Atisha-Fregoso, J Suurmond, B Diamond Frontiers in immunology 9, 427, 2018 | 128 | 2018 |
| Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells EP Buddingh, MW Schilham, SEN Ruslan, D Berghuis, K Szuhai, ... Cancer immunology, immunotherapy 60, 575-586, 2011 | 107 | 2011 |
| Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies J Suurmond, F Rivellese, AL Dorjée, AM Bakker, Y Rombouts, T Rispens, ... Annals of the rheumatic diseases 74 (10), 1915-1923, 2015 | 103 | 2015 |
| Activation of human basophils by combined toll‐like receptor‐and FcεRI‐triggering can promote Th2 skewing of naive T helper cells J Suurmond, JN Stoop, F Rivellese, AM Bakker, TWJ Huizinga, REM Toes European journal of immunology 44 (2), 386-396, 2014 | 73 | 2014 |
| Communication between human mast cells and CD4+ T cells through antigen‐dependent interactions J Suurmond, J van Heemst, J van Heiningen, AL Dorjée, MW Schilham, ... European journal of immunology 43 (7), 1758-1768, 2013 | 66 | 2013 |
| Ability of Interleukin‐33–and Immune Complex–Triggered Activation of Human Mast Cells to Down‐Regulate Monocyte‐Mediated Immune Responses F Rivellese, J Suurmond, K Habets, AL Dorjée, N Ramamoorthi, ... Arthritis & Rheumatology 67 (9), 2343-2353, 2015 | 61 | 2015 |
| Differential TLR‐induced cytokine production by human mast cells is amplified by FcɛRI triggering J Suurmond, AL Dorjée, EF Knol, TWJ Huizinga, REM Toes Clinical & Experimental Allergy 45 (4), 788-796, 2015 | 53 | 2015 |
| Loss of an IgG plasma cell checkpoint in patients with lupus J Suurmond, Y Atisha-Fregoso, E Marasco, AN Barlev, N Ahmed, ... Journal of Allergy and Clinical Immunology 143 (4), 1586-1597, 2019 | 52 | 2019 |
| IgE and IL‐33− mediated triggering of human basophils inhibits TLR4− induced monocyte activation F Rivellese, J Suurmond, A de Paulis, G Marone, TWJ Huizinga, ... European journal of immunology 44 (10), 3045-3055, 2014 | 44 | 2014 |
| The production and secretion of complement component C1q by human mast cells RA van Schaarenburg, J Suurmond, KLL Habets, MC Brouwer, D Wouters, ... Molecular Immunology 78, 164-170, 2016 | 43 | 2016 |
| Mast cells in rheumatic disease J Suurmond, D van der Velden, J Kuiper, I Bot, REM Toes European journal of pharmacology 778, 116-124, 2016 | 39 | 2016 |
| DNA-reactive B cells in lupus J Suurmond, J Calise, S Malkiel, B Diamond Current Opinion in Immunology 43, 1-7, 2016 | 36 | 2016 |
| Patterns of ANA+ B cells for SLE patient stratification J Suurmond, Y Atisha-Fregoso, AN Barlev, SA Calderon, MC Mackay, ... JCI insight 4 (9), 2019 | 32 | 2019 |
| Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis J Suurmond, YR Zou, SJ Kim, B Diamond Science translational medicine 7 (280), 280ps5-280ps5, 2015 | 28 | 2015 |
| Expansion of Th17 Cells by Human Mast Cells Is Driven by Inflammasome-Independent IL-1β J Suurmond, KLL Habets, AL Dorjée, TW Huizinga, REM Toes The Journal of Immunology 197 (11), 4473-4481, 2016 | 26 | 2016 |
| Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue J Suurmond, KLL Habets, Z Tatum, JJ Schonkeren, P AC't Hoen, ... Journal of Allergy and Clinical Immunology 138 (3), 869-880, 2016 | 24 | 2016 |
| Human mast cells costimulate T cells through a CD28‐independent interaction J Suurmond, AL Dorjée, TWJ Huizinga, REM Toes European journal of immunology 46 (5), 1132-1141, 2016 | 13 | 2016 |
| FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation AN Barlev, S Malkiel, I Kurata-Sato, AL Dorjée, J Suurmond, B Diamond The Journal of Clinical Investigation 132 (17), 2022 | 12 | 2022 |
